ARCHIVES

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

This article is from The Cancer Letter archive.

Vol. 20 No. 22 | June 3, 1994

Download PDF Visit The Full Archive

Related Articles

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998

NIH Should Review CRADA Pricing, Wyden Write to Shalala

February 5, 1993

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988